1. Home
  2. RNAZ vs BNRG Comparison

RNAZ vs BNRG Comparison

Compare RNAZ & BNRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RNAZ
  • BNRG
  • Stock Information
  • Founded
  • RNAZ 2016
  • BNRG 2012
  • Country
  • RNAZ United States
  • BNRG Israel
  • Employees
  • RNAZ N/A
  • BNRG N/A
  • Industry
  • RNAZ Biotechnology: Pharmaceutical Preparations
  • BNRG
  • Sector
  • RNAZ Health Care
  • BNRG
  • Exchange
  • RNAZ Nasdaq
  • BNRG Nasdaq
  • Market Cap
  • RNAZ 6.1M
  • BNRG 5.2M
  • IPO Year
  • RNAZ 2021
  • BNRG 2022
  • Fundamental
  • Price
  • RNAZ $9.11
  • BNRG $2.14
  • Analyst Decision
  • RNAZ Strong Buy
  • BNRG
  • Analyst Count
  • RNAZ 1
  • BNRG 0
  • Target Price
  • RNAZ $280.00
  • BNRG N/A
  • AVG Volume (30 Days)
  • RNAZ 26.1K
  • BNRG 256.1K
  • Earning Date
  • RNAZ 08-13-2025
  • BNRG 08-29-2025
  • Dividend Yield
  • RNAZ N/A
  • BNRG N/A
  • EPS Growth
  • RNAZ N/A
  • BNRG N/A
  • EPS
  • RNAZ N/A
  • BNRG N/A
  • Revenue
  • RNAZ N/A
  • BNRG N/A
  • Revenue This Year
  • RNAZ N/A
  • BNRG N/A
  • Revenue Next Year
  • RNAZ N/A
  • BNRG N/A
  • P/E Ratio
  • RNAZ N/A
  • BNRG N/A
  • Revenue Growth
  • RNAZ N/A
  • BNRG N/A
  • 52 Week Low
  • RNAZ $6.15
  • BNRG $1.78
  • 52 Week High
  • RNAZ $905.52
  • BNRG $15.30
  • Technical
  • Relative Strength Index (RSI)
  • RNAZ 55.86
  • BNRG 35.95
  • Support Level
  • RNAZ $8.04
  • BNRG $1.98
  • Resistance Level
  • RNAZ $9.70
  • BNRG $2.73
  • Average True Range (ATR)
  • RNAZ 0.67
  • BNRG 0.23
  • MACD
  • RNAZ 0.27
  • BNRG 0.00
  • Stochastic Oscillator
  • RNAZ 75.08
  • BNRG 14.63

About RNAZ TransCode Therapeutics Inc.

TransCode Therapeutics Inc is a biopharmaceutical company focused on developing and commercializing innovative drugs and diagnostics for treating and identifying cancer. TransCode recently commenced its first clinical trial. The Company's lead therapeutic candidate, TTX-MC138, comprises an oligonucleotide conjugated to an iron oxide nanoparticle designed to be administered by infusion to inhibit the ability of metastatic tumor cells to survive. The goal of the therapy, if approved, is to achieve durable disease regression and long-term patient survival.

About BNRG Brenmiller Energy Ltd

Brenmiller Energy Ltd is a technology company that develops, produces, markets, and sells thermal energy storage. The technology of the company allows electrification and decarbonization of the industrial industry sector for integration with renewable energy sources and further reduction of carbon emissions.

Share on Social Networks: